Valued Capital

Valued Capital is an independent publication on companies with immense long-run growth potential. I focus on those I believe are poised to be winners and 'category-defining' companies. I employ a high-conviction approach, hence the list is deliberately brief.

Disclaimer

‘Valued Capital’ is an independent publication and not an investment firm or vehicle. Nothing on this site constitutes investment advice, the indication of any financial service, nor an offer or solicitation to buy or sell any security or other financial instrument.

The views expressed are those of the author alone and reflect information available at the time of writing. Valuations are drawn from public sources or are estimates by the author and may be incomplete or inaccurate or out of date.

Company names and logos are the property of their respective owners and are shown for identification only. No affiliation with or endorsement by any company shown is implied.

Valuation figures "()" are derived from latest disclosed funding rounds with asterisks reflecting estimated valuations.

Companies

• Allia Health: AI / Health ($25m*)
• Chowdeck: Consumer / Logistics ($50m*)
• Consensus: AI ($175m)
• Jack & Jill: AI / Marketplaces ($100m*)
• Luma: Consumer ($100m*)
• Natural: AI / Fintech ($150m)
• NavigateAI: AI / Other ($225m)
• Nory: AI / SaaS ($200m*)
• Profound: AI ($1.8bn)
• Self: SaaS / B2B ($40m*)
• Tuyo: Fintech ($75m*)